Aric Sharp announced as Divisi
FRANKLIN, Tennessee, May 09, 2022 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (CLOV) (“Clover” or “Clover Health”), a physician empowerment company committed to improving health equity for older adults, today announced the appointment of Aric Sharp as Managing Director (“CEO”) of Value Based Care for Clover. Sharp will lead all value-based healthcare operations for the business, including for Clover Health Partners, Clover’s direct contracting entity (“DCE”).
Sharp is recognized as a national leader in the transition of healthcare to value, innovation and medical practice management and is president-elect of the American Medical Group Association. In his former role as Senior Vice President and Chief Transformation Officer at INTEGRIS Health, he led the system’s journey to value-based care, including launching INTEGRIS’ participation in the direct contract model, a plan Medicare Advantage and Oklahoma’s first virtual hospital.
Sharp will begin by overseeing the transition of Clover Health Partners to meet the requirements of the evolved Accountable Care Organization (“ACO”) model for achieving equity, access and community health (“REACH”) , which will come into force in 2023.
“We are excited to welcome Aric to the Clover family, and believe his experience in leading efforts to transform payers’ innovation strategies around value-based agreements will position him well to lead Clover Health Partners throughout throughout its transition to the ACO REACH model,” said Vivek, CEO of Clover. Garipalli. “Additionally, Aric’s expertise in physician relations and ability to strategize and implement with a focus on provider education, buy-in and engagement will be a tremendous asset. for Clover as we look to expand our provider network and embrace the Clover Assistant.”
Prior to INTEGRIS, Sharp served as Vice President for Accountable Care at UnityPoint Health, where he developed and led UnityPoint Accountable Care, one of the largest and most successful ACOs in the nation, with more than 8,000 physicians , 40 hospitals and more than $1.5 billion in medical expenses. under risk, including the largest next-generation ACO model in the country. Earlier in his career, Sharp held various leadership positions, including CEO and COO for Quincy Medical Group and The Iowa Clinic, respectively, two of the nation’s most successful multi-specialty medical groups.
“I am excited to join Clover because I see an opportunity to develop and implement a myriad of value-based population health and care initiatives to further strengthen the company’s existing efforts in ECD. My primary goal is to drive network growth and adoption of Clover’s physician empowerment technology to make value-based care more accessible to physicians across the country, and therefore more patients,” Sharp said.
About Clover Health:
Clover Health (CLOV) is a physician empowerment society focused on seniors who have never had access to affordable, high-quality health care. Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve healthcare outcomes. We operate two distinct lines of business: insurance and non-insurance. Through its Insurance segment, the company offers PPO and HMO plans to Medicare Advantage members in several states. The Company’s Non-insurance segment includes its operations related to its participation in CMS’s direct contract model, which will transition to the ACO REACH model beginning in 2023. Clover is headquartered in Franklin, Tennessee.
Learn more about our health equity strategy: www.cloverhealth.com/healthequity
Learn more about Clover Assistant: www.cloverassistant.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events and the future results of Clover’s operations, its financial condition, market size and opportunities, business strategy and plans, and factors affecting Clover’s performance and objectives. Clover for future transactions. Forward-looking statements are not guarantees of future performance and you are cautioned not to place undue reliance on such statements. In some cases, you can identify forward-looking statements because they contain words such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “will”, “may”, “could”, “should”, “would”, “intend”, “target”, “plan”, “plan”, “believe”, “estimate”, “predict”, “potential “, “perspective”, “plans”, “direction”, “goal”, “plan”, “seek”, “grow”, “target”, “if”, “continue” or the negative of these words or d other similar terms or expressions that relate to Clover’s expectations, strategy, priorities, plans or intentions. Additional information regarding these and other risk factors is contained in the Risk Factors section included in Clover’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which has been filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2022 and in Clover’s other filings with the SEC. The forward-looking statements included in this press release are made as of the date hereof. Except as required by law, Clover undertakes no obligation to update any of these forward-looking statements after the date of this press release or to conform these statements to actual results or revised expectations.
Derrick Nueman and Ryan Schmidt